Navigation Links
NxStage Medical Reports Third Quarter 2007 Results
Date:11/2/2007

LAWRENCE, Mass., Nov. 2 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), the manufacturer of the NxStage System One(TM) portable kidney dialysis machine, today announced its financial results for the third quarter ended September 30, 2007.

Revenues for the third quarter of 2007 were $11.6 million, compared to $5.5 million in the third quarter of 2006, an increase of 111%. Revenues in the chronic home dialysis market were $8.3 million for the third quarter of 2007, compared to $3.6 million in the third quarter of 2006. Revenues in the critical care market for the third quarter of 2007 were $3.3 million, compared to $1.9 million in the third quarter of 2006. For the nine months ended September 30, 2007 revenue was $30.0 million, a 123% increase over revenue of $13.5 million for the first nine months of 2006.

At the end of the third quarter of 2007, NxStage was working with 306 dialysis centers to provide home hemodialysis therapy with its System One to 1,957 end-stage renal disease (ESRD) patients. This compares to 265 centers and 1,615 patients at the end of the second quarter of 2007. NxStage also continued to expand use of the PureFlow SL to a broader customer base and at the end of the third quarter 2007, PureFlow penetration reached 65% of all System One machines in the chronic market. Expanding penetration of PureFlow among existing and new customers is an important element of NxStage's ongoing focus to improve margins.

"NxStage continues to validate the home hemodialysis opportunity and in the second quarter we demonstrated our ability to lead and grow this market," said Jeffrey H. Burbank, President & CEO of NxStage Medical. "Our recently completed acquisition of Medisystems mark
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009).... 9 Sutter Health, a family of doc...re service providers, is donating $255,000 to food...cal food banks will share the quarter-million-doll...ables of thousands of families across the north st...artnering with and supporting charitable programs ...
(Date:11/9/2009)... with drugs that inhibit estrogen, , , ...to treat breast cancer and osteoporosis eliminated.... , The drugs also cleared precancerous growths... of cancer in mice with precancerous lesions. ,... cancer/osteoporosis drug raloxifene were given to...
(Date:11/9/2009)...both eye conditions are age-related, researchers s...- Cataract surgery doesn,t appear to speed the pro..., according to a new study that challenges the bel... the other. , "Because both conditions are stro...lso have AMD," wrote Li Ming Dong, of Stony Brook ...
(Date:11/9/2009)... /PRNewswire-FirstCall/ - Hard To Treat Diseases (...at Novartis, a US$41 billion international healthc...N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmace...Switzerland will begin a five-year, $1 billion Chi...atically increase its investment in its China R&am...
(Date:11/9/2009)...ive Cancer Network (NCCN) has posted a draft white...adigm for near-term comparative effectiveness clin...ument introduces the NCCN Comparative Therapeutic ...mpares the risk-versus-benefit of different treatm...ice Guidelines in Oncology(TM). The paper will be ...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...more than 25,000 foods and 10,000 ...stop resource for counting carbohydrates -, WESTP...,community resource, today announced the launch of...tes. Visit, http://www.dlife.com/nutrition and se...
...orldwide cancer incidence, researchers at the Moor...Diego (UCSD) and the Department of Family and Prev...ween deficiency in exposure to sunlight, specifica...le through diet and supplements. , Approximately...
...t action in Sierra acquisition was,inadequate and ...can Medical,Association, Nevada State Medical Asso...ounced they have filed joint comments seeking to r...physician organizations filed comments to the DOJ ...
...usiness,Council (USCBC) today encouraged American ...der way in China in response to the devastating ea...CBC member companies have already pledged several ...The US-China Business Council (USCBC) has expresse...
...is a,statement from Larry Minnix, President & CEO,...e Aging:, "Today,s GAO report points out yet agai...and certification of nursing homes in this country...ever, that simply raising penalties will lead,to q...
...hina Youth Federation; sending more,aid workers, ...youth cope, PORTLAND, Ore., May 15 Mercy Corps,e... reports that better,weather has opened up transpo...include food and,shelter: biscuits, water, milk, n...
Other Medicine News:Health News:dLife Launches the World's Largest and Most Comprehensive Online Food and Diabetic Recipe Search Tool 2Health News:UCSD researchers show link between vitamin D status, breast cancer 2Health News:Physicians Charge Health Insurer Merger Not In The Public Interest 2Health News:US Companies Aid Chinese Earthquake Victims 2Health News:US Companies Aid Chinese Earthquake Victims 3Health News:US Companies Aid Chinese Earthquake Victims 4Health News:US Companies Aid Chinese Earthquake Victims 5Health News:US Companies Aid Chinese Earthquake Victims 6Health News:US Companies Aid Chinese Earthquake Victims 7Health News:Mercy Corps Delivers Lifesaving Supplies to China Earthquake Survivors 2
(Date:11/9/2009)...PLEASANTON, Calif., Nov. 9 /PRNewswire-FirstCall/ ...leader in device-based mechanical circulatory supp... hearts, said today that it will be participating ...rence on Tuesday, November 10. ,, The presentat...ive officer, will begin at 8 a.m., Pacific Standar...
(Date:11/9/2009)...SAN DIEGO, Nov. 9 Volcan...velopment, manufacture and sales of products for t...ral artery disease, said today that it will be par...cular Conference on Tuesday, November 10. ,, Th...chief executive officer, will begin at 1 p.m., Pac...
(Date:11/9/2009)...BIRMINGHAM, Ala., Nov. 9 ...that it will host an investor conference call at 1...9, to discuss its 2009 third quarter operating res...tely an hour following the conclusion of the confe.../cgi-bin/prnh/20080812/CLTU111LOGO ) ,, Plea...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Emission capture study funded for paper industry 10353 1Emission capture study funded for paper industry 10353 2Emission capture study funded for paper industry 10353 3Chimpanzees help each other on request but not voluntarily 10350 1Chimpanzees help each other on request but not voluntarily 10350 2SIMNSA is added to the Satori Global Network 26amp 3B 238482 3B in Mexico to Offer U S Employers Cross Border Health Benefit Options 59446 1SIMNSA is added to the Satori Global Network 26amp 3B 238482 3B in Mexico to Offer U S Employers Cross Border Health Benefit Options 59446 2
...LIS, France, Nov. 20 NicOx S.A. (Eurolist:,COX) t...as dosed the first,patients in a phase 2 proof of ...Pulmonary Disease (COPD) - see TOPIGEN press relea... the first assessment of TPI 1020,s,potential acti...d novel,anti- inflammatory licensed by TOPIGEN fro...
...strated powerful mean blood pressure reductions of... mm Hg diastolic blood pressure (DBP),at five week...ne in a study of patients with se...BP reductions of 27.1/14.6 mm Hg (SBP/DBP), at 8 .../DBP) reductions, respectively for irbesartan and...
Other Medicine Technology:NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 2NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 3NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 4NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 5NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 6NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 7Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 3Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 4Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 5Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 6Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 7
COULTER AcT diff2 (Recertified)
mini VIDAS - Recertified
ACE Alera
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: